The RB tumour suppressor is well known for its ability to repress transcription and to prevent cell proliferation by arresting cells either in G1, at the G1/S transition or in S phase of the cell cycle. The functional inactivation of RB compromises the ability of cells to respond to signals that normally suppress cell proliferation and results in the mis-expression of genes that drive cell division. Lesions that lead to the functional inactivation of RB are thought to occur in most cancer cells, creating a cellular environment that is permissive for inappropriate cell proliferation.
The RB tumour suppressor is well known for its ability to repress transcription and to prevent cell proliferation by arresting cells either in G1, at the G1/S transition or in S phase of the cell cycle. The functional inactivation of RB compromises the ability of cells to respond to signals that normally suppress cell proliferation and results in the mis-expression of genes that drive cell division. Lesions that lead to the functional inactivation of RB are thought to occur in most cancer cells, creating a cellular environment that is permissive for inappropriate cell proliferation.
Whole-chromosome aneuploidy is another common feature of cancer cells. The frequent gains and losses of whole chromosomes is termed chromosome instability (CIN) [1] [2] [3] . CIN, by definition, results in the generation of aneuploid cells [4] [5] [6] [7] [8] [9] and has important implications for cancer. For example, it has been demonstrated that 'shuffling' of genomic content by CIN can facilitate both the loss of heterozygosity (LOH) of tumour suppressor genes and an increased copy number of oncogenes. Furthermore, the genomic diversity that is generated by CIN promotes the development of cancer cells that are resistant to therapeutics and are more prone to tumour relapse 1, [10] [11] [12] [13] [14] [15] [16] [17] [18] . Consequently, CIN correlates with poor patient prognosis 1, 3, 18 . The changes that result in aneuploidy are poorly understood. It is likely that there is not one cause, but multiple contributory factors. Identifying the events that are responsible for the mitotic defects underlying CIN is an important goal.
Recent work has demonstrated that the inactivation of RB and the RB-related proteins p107 (also known as RBL1) and p130 (also known as RBL2), which are collectively known as the pocket proteins, leads to defects in mitotic progression and increases the likelihood of chromosome mis-segregation (reviewed in REF. 19 ). Given the frequency of defects in the RB pathway in cancer cells, these studies raise the tantalizing idea that the mutational events that promote tumour cell proliferation may also contribute to much of the aneuploidy that is seen in tumour cells.
The mechanistic connection between RB family proteins and aneuploidy is not completely understood. Part of the puzzle arises from the fact that RB is regulated by phosphorylation that is mediated by cyclindependent kinases (CDKs), and is generally thought to be converted to a functionally inactive state as cells progress towards S phase, long before cells enter mitosis. If the conventional view of RB regulation and action is correct, then any link between RB and mitotic fidelity must be indirect. RB is a multifunctional protein, and its inactivation has been shown to affect several different processes. There are multiple ways by which RB might plausibly influence mitotic progression and here we summarize three different explanations that have been proposed in a series of recent publications (FIG. 1) . We note that although the models are different, they are not mutually exclusive. Potentially, the different types of changes summarized below may have synergistic effects, with the cumulative effect of promoting genomic instability in tumour cells.
Altered expression of mitotic genes
The best-characterized function of RB is its role in the regulation of E2F transcription factors. Numerous genes are expressed at elevated levels in an E2F-dependent manner following the inactivation of RB. These include several genes, the products of which have known roles in mitosis 7, [20] [21] [22] and have been linked to CIN 18, 23, 24 . One of the most notable of these E2F targets is the spindle-assembly checkpoint (SAC) protein MAD2. MAD2 overexpression is sufficient to induce CIN both in vivo and in vitro 18 . Not only are MAD2 levels increased following the inactivation of RB1 in certain contexts, but recent experiments have also demonstrated that reducing the levels of MAD2 in a mouse model of cancer delays tumour onset, reduces tumour burden and results in tumours with a more stable karyotype 9 . Together these studies provide strong evidence that deregulated expression of MAD2 promotes CIN and that this, at least in some contexts, drives tumorigenesis. Interestingly, MAD2 expression is upregulated by the inactivation of both the p53 and RB pathways. Recent experiments also indicate that the loss of RB alone is not sufficient to deregulate MAD2 expression as its regulation also depends on RB-related proteins. Thus, the elevated expression of MAD2 may reflect the combined effects of perturbations in several tumour suppressor pathways.
MAD2 regulates mitotic progression by inhibiting the anaphase promoting complex/ cyclosome (APC/C)-cell division cycle 20 (CDC20) complex; inhibition of this E3 ubiquitin ligase promotes the activity of the SAC. The SAC prevents the premature protease-dependent cleavage of cyclin B and cohesin, which is required to maintain sisterchromatid cohesion. Ultimately, the cleavage of cohesin initiates anaphase progression and allows chromosome segregation. Precisely why elevated levels of MAD2 cause errors in chromosome segregation is not certain. Shvartzman et al. 9 have suggested that elevated MAD2 expression may delay cohesin cleavage, resulting in the improper segregation of sister chromatids and leading to DNA damage. This hypothesis has yet to be directly tested, and it is also possible that MAD2-induced aneuploidy involves activities of MAD2 that extend beyond the SAC and/or mitosis. In cells in which MAD2 expression is deregulated, increased levels of MAD2 are seen throughout the cell cycle. In addition, recent studies have uncovered a SAC-independent role for MAD2 in the regulation of kinetochore-microtubule attachments, which thus affects the stability of these attachments and the occurrence of merotelic attachments (a kinetochore attached to microtubules from both spindle poles) that may be important in the generation of CIN (D. Compton and colleagues, Dartmouth Medical School, USA, personal communication).
Although MAD2 is clearly important, it is unlikely to be the sole E2F target that links RB pathway defects to the generation of aneuploidy. Segregation errors have been described following RB depletion under conditions in which MAD2 expression is not detectably increased 25 . Even in the experiments that have been used to show that reduced MAD2 expression reduces chromosome segregation errors, the effect is partial. Other E2F targets, including centromere protein A (CENPA) and HEC1 (also known as NDC80), also have well defined roles in mitosis (FIG. 2; TABLE 1 ) and promote chromosome segregation errors when overexpressed 4, 26, 27 . Indeed, several E2F target genes were listed among the most highly misregulated genes in a gene expression profile signature of tumours with CIN 22, 28 . It is unclear whether this association occurs because of a specific link between E2F deregulation and CIN, or whether the gene expression changes simply reflect changes in the rates of cell proliferation. In most cases, the functional consequences of E2F-driven changes in the expression of mitotic genes are not known, and some of these changes may even promote, rather than suppress, proper segregation. In addition, in some cell types the inactivation of RB undermines the normal coupling of replication and mitotic progression [29] [30] [31] . The resulting endoreduplication produces polyploid cells, which, if competent to proceed through subsequent mitoses, can lead to CIN that is irrespective of additional changes in gene expression 32 .
Given that no two gene expression profiling experiments show precisely the same lists of deregulated E2F target genes in different tumour cells, it is easy to imagine that the importance of individual E2F targets might vary in different tumour cells, depending on the combinations of mutations that are present and on the extent to which different genes are deregulated. Nevertheless, these studies indicate that the altered expression of mitotic proteins is one way by which the inactivation of RB family proteins influences progression through mitosis and reduces the fidelity of chromosome segregation.
Influence on replication progression
Recent work from Bester and colleagues 33 has highlighted a different type of cellular stress that occurs when RB family members are inactivated and E2F is deregulated. In this study, the authors demonstrated that expression of the human papilloma virus (HPV) oncoprotein E7, which targets and thereby inactivates RB, p107 and p130, alters S phase progression and promotes the stalling of replication forks. Replication fork stalling is especially prevalent at repetitive regions of the genome, including fragile sites, and is associated with increased levels of markers of DNA damage and with a high frequency of LOH 33 . The list of E2F-regulated genes that are deregulated following E7 expression includes several genes that are necessary for nucleotide synthesis. Bester et al. 33 proposed that the altered replication dynamics are largely a consequence of suboptimal nucleotide pools. In support of this, they showed that adding nucleosides to the cell culture media gives a strikingly strong suppression of the replication defects in E7-expressing cells.
This work adds to several studies that have linked RB with the control of DNA replication. Through its effects on E2F, the loss of RB alters the expression of numerous proteins that are needed for S phase, and RB and E2F proteins have also been shown to physically interact with replication factors 21, 31, 34, 35 (FIG . 2) . Changes in the levels and/or activity of replication proteins may influence the process of DNA replication in RB-deficient cells in multiple ways. RB loss has been shown to alter the spatial organization of DNA synthesis within the nucleus 36 and to affect the slowing of replication fork progression in the presence of genotoxic stress 37 . The normal slowing of replication forks is thought to suppress the formation of double strand DNA breaks (DSBs) 38 . Although there is an unexplained contradiction in the observations that the disruption of the RB pathway promotes replication fork stalling 33 and at the same time prevents slowing of replication fork progression in response to replication stress 37 , such studies highlight the fact that the loss of RB disrupts the normal process of DNA replication.
The analysis of replication fork progression in HPV E7-expressing cells shows that stalling occurs particularly at repetitive regions of the genome and results in DSBs 33 . In normal cells, DSBs would be repaired before entry into mitosis. However, the E2F pathway also regulates the expression of numerous components of the DNA damage response and repair pathways 35 , and various studies have shown that DNA damage checkpoints are compromised when the RB pathway is corrupted and cells can enter mitosis with unrepaired breaks [39] [40] [41] [42] (FIG. 1) .
The presence of DSBs during mitosis has several potential consequences. DSBs can activate the SAC 43 , and sustained activation may influence mitotic fidelity in a similar manner to that proposed for MAD2 overexpression. Additionally, unresolved DNA damage, particularly damage at centromeres or telo meres, may directly compromise chromosome segregation during mitosis and result in the generation of aneuploid daughter cells.
These results raise the possibility that the mitotic abnormalities that are seen in RB-deficient cells are a consequence of changes that occurred much earlier in the cell cycle. The idea that RB is necessary for normal replication, and that its loss causes replication fork stalling and DSBs, is consistent with multiple studies showing that loss 
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of RB results in increased DNA damage, and that elevated DNA damage in turn results in increased genomic instability 23, 39, [44] [45] [46] [47] . Indeed, Bester et al. 33 suggest that much of the DNA damage, CIN and genomic instability seen when RB is inactivated is an indirect consequence of replication fork stalling that results from deregulated E2F. RB loss and chromosome structure A third connection between RB and chromosome segregation has been provided by studies describing chromatin changes in cells in which the RB family members are inactivated. Such changes include general defects in chromatin condensation, as well as more specific changes in the architecture of the telomeric and centromeric regions 5, 8, [48] [49] [50] [51] . The ability of RB to recruit regulatory complexes to chromatin is one of the molecular features that enable it to regulate transcription. RB family members are thought to localize primarily to promoter regions. The reason why RB loss affects higher-order chromosome structures is uncertain, but may involve both the loss of complexes that are recruited by RB, as well as changes in the expression of RB-regulated genes. Various chromatin regulators are recruited to chromatin by RB, including several proteins with important roles in the formation of heterochromatin 49, [52] [53] [54] [55] [56] . In addition, the RB family of proteins physically interact with components of the condensin II complex and influence the localization of both the condensin and cohesin complexes to chromatin 8, 51 , with the changes being most evident at the centromere.
Changes in centromere structure may be particularly relevant to the generation of chromosome segregation errors. The specific depletion of RB from non-transformed cells results in mitotic defects, such as merotely. Changes in centromeric structure, including changes that are caused by a reduction in the centromeric composition of condensin and cohesin complexes, similar to the defects that are seen in RB-depleted cells, are known to promote mal-attachment of the chromosome to the mitotic spindle, and thereby promote segregation errors 57, 58 . Although the deformation of centromeric structure is associated with defects during mitosis, the loading of condensin and cohesin complexes onto chromatin begins much earlier in the cell cycle, and changes in the stability of their association with chromatin are tightly coordinated with cell cycle progression. Condensin II and cohesin complexes are loaded onto chromatin as early as telophase, and cohesin is additionally loaded onto newly synthesized chromatin concurrently with replication. However, chromatin association alone is not sufficient for function, and both complexes are additionally regulated by post-translational modifications. For example, acetylation of the structural maintenance of chromosomes 3 (SMC3) subunit of cohesin converts what was merely chromatin association to a functional cohesion between replicated sister chromatids 59 . Whether the altered patterns of DNA replication that are seen in RB-depleted cells change either the loading or stability of cohesin or condensin complexes is not yet known.
The characterization of a mutant allele of mouse Rb1 -that encodes an RB mutant that can regulate E2F-dependent transcription but is defective for interaction with chromatin regulators including the condensin II protein CAPD3 -suggests that the ability of RB to recruit these complexes to chromatin contributes to its tumour suppressor activity, at least when combined with p53 mutation 5 . Taken together, these studies suggest that inactivation of RB proteins causes changes in chromosome structure, that these defects promote segregation errors and that this property of RB is relevant to tumour suppression.
A CINful path
Given the multifaceted roles of RB in the control of gene expression and chromatin structure, it would be remarkable if there was a single feature of RB-deficient cells that sufficiently explains all of the mitotic defects and the propensity for CIN. A more likely scenario is that these properties represent the accumulated effect of multiple changes. As described above, the inactivation of RB leads to the mis-expression of proteins that have important functions in mitosis, the stalling of replication forks, elevated DNA damage and altered chromosome structure. Each phenotype can be studied in isolation, but all are present when the RB family is inactivated (FIG. 2) , and we note that there are several ways in which these different types of changes are interconnected and may synergize with one another (FIG. 3) .
It is likely that some of the mitotic defects that are associated with RB loss originate in S phase. Defects in replication fork progression may leave unreplicated regions of the genome and promote DSBs that, if not resolved, interfere with mitotic progression and chromosome segregation 60 . Replication fork stalling is especially prevalent at repetitive regions of the genome. Given that centromeric and telomeric regions are composed of highly repetitive sequences, these regions may be common locations for stalled replication forks when RB is inactivated. In addition, changes in replication dynamics may also alter the distribution (or activity) of cohesin and condensin II components. Because these complexes serve an essential role at the mitotic centromere, this region might be particularly vulnerable to alterations of cohesin and condensin II. However, cohesin and condensin complexes have also been shown to serve important roles in replication fork progression, as well as in the prevention and efficient repair of DSBs [61] [62] [63] , any of which could contribute to genomic stability. These overlapping and interconnected roles in replication Figure 2 | RB-mediated effects on the progression of S phase through to mitosis. The RB-E2F pathway has well characterized roles in the regulation of quiescence, senescence and entry into S phase. RB also regulates the expression of genes that act at later stages of the cell cycle and has been shown to physically interact with proteins that function during these stages 7, [20] [21] [22] 34, 35, [40] [41] [42] . As a result, the functional inactivation of RB does not simply affect the regulation of G1 phase, but influences later cell cycle events. Changes that occur at any of these steps can be detrimental to genomic stability. AURKA, aurora kinase A; BARD1, BRCA1-associated RING domain 1; CENPE, centromere protein E; HDAC, histone deacetylase; MCAK, mitotic centromereassociated kinesin; MCM, minichromosome maintenance complex component; PCNA, proliferating cell nuclear antigen; RPA, replication protein A; RR, ribonucleotide reductase; SMARCA, SWI/SNF-related, matrix associated, actin dependent regulator of chromatin, subfamily A; SMC, structural maintenance of chromosomes; SUV420H, suppressor of variegation 4-20 homologue; TS, thymidylate synthase.
and chromatin structure are an example of how various defects resulting from RB misregulation may cooperate to promote CIN.
An additional way in which the various defects may interact is in the promotion of merotely. Merotelic attachment is thought to be a prominent cause of CIN in cell lines and of chromosome segregation errors in tumours [64] [65] [66] . Chromosome association with the microtubules of the mitotic spindle is a complex process and is regulated at multiple levels. This complexity has made it difficult to discern the mechanism or mechanisms behind such erroneous attachments 60 . RB-depleted cells show evidence of merotelic attachments, and at least two distinct changes may cooperate to promote this. Potentially, the altered centromere Regulates mitotic entry and spindle assembly, and promotes microtubule disassembly Binds microtubule dimers Promotes microtubule dynamics required for spindle assembly APC/C, anaphase promoting complex/cyclosome; AURKA, aurora kinase A; CCN, cyclin; CDC20, cell division cycle 20; CDK, cyclin-dependent kinase; KIF, kinesin family member; NEB, nuclear envelope breakdown; NEK2, NIMA-related kinase 2; NUSAP1, nucleolar and spindle-associated protein 1; PLK1, polo-like kinase 1; PRC1, protein regulator of cytokinesis 1; SA, stromal antigen; SAC, spindle-assembly checkpoint; SMC, structural maintenance of chromosomes; STMN1, stathmin 1. *For details see REFS 7,21,22. Although there are many potential changes in the levels and/or activity of mitotic proteins, we note that the relative importance of the individual changes is not known, and it is unclear how many of these events lead to specific mitotic defects. ‡ Also upregulated as a part of a chromosome instability expression profile 28 . § Has been reported to be in a complex with RB 34, 51 . Nature Reviews | Cancer
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Changes in chromatin structure (Histone modifications, condensin II and cohesin distribution) Defects in replication progression (Especially at repetitive regions including fragile sites, centromeres and telomeres) structure in RB-deficient cells may be more prone to the formation of merotelic attachments. In addition, the overexpression of kinetochore components (for example, HEC1 and MAD2) may stabilize erroneous attachments, thereby preventing correction. Finally, the E2F-dependent upregulation of MAD2 expression has been shown to delay progression through mitosis 23 , a change that may enhance defects in sister-chromatid cohesion in RB-depleted cells 8, 67 , which would further promote erroneous attachments. Together, these changes may make RB-deficient cells prone to the formation of merotelic attachments, and/or make them slower to correct such problems. In addition to promoting CIN, merotelic attachments have also recently been shown to lead to structural chromosome abnormalities as a result of DNA breaks during cytokinesis 68 . These connections illustrate how defects in DNA replication might cause and be compounded by changes in chromosome structure, and how these changes, together with persistent DSBs, may exacerbate problems resulting from the mis-expression of mitotic proteins. The idea that all these changes are interconnected raises the key question of whether correcting any one of these defects would be sufficient to prevent aneuploidy and CIN. Using viral oncoproteins to inactivate RB, published work has shown that reducing MAD2 levels is sufficient to partially suppress aneuploidy and CIN 9 , and that nucleoside supplementation can reduce the frequency of DSBs 33 . Although it is an important point, it is not yet known whether the manipulations that correct chromosome defects in RB-deficient cells affect the rates of aneuploidy and CIN. Clearly, further studies are needed to compare each of these approaches and to determine which strategy can be most easily exploited to suppress CIN.
Mitotic fidelity and tumour suppression
There is compelling evidence that the inactivation of RB causes mitotic defects and promotes aneuploidy. However, for several reasons it is currently unknown how often these defects contribute directly to the pathogenesis of human tumours.
First, although mitotic defects, CIN and genomic changes occur when RB is inactivated, these changes are often more obvious when multiple RB family members are targeted, and this seems to be particularly true in mouse studies. In some cancer cells RB is inactivated by the deletion or mutation of RB1, but in others RB is functionally inactivated through the expression of viral oncoproteins or through the increased activity of CDKs that not only inactivate RB but also affect the RB family members p107 and p130. Although different types of lesion in the RB pathway can promote aneuploidy 19 , it is not clear whether the underlying mechanism is the same in each case. It is also not yet known whether the mitotic phenotypes summarized here will be most relevant in human tumours that have RB1 mutations, or in tumour cells in which all three RB family members are inactivated either directly by the expression of viral oncoproteins (such as E7) or indirectly by deregulated CDKs.
Second, for CIN to promote tumorigenesis, tumour cells must tolerate genomic change. The ability of cells to tolerate aneuploidy depends heavily on the presence of additional mutations, such as p53 inactivation, and this suggests that the genetic background of a tumour may be very important. It is noteworthy that several studies that have examined the effects of targeting RB have used cells that lack functional p53 (REFS 5, 9) and/or cells in which all three RB family members are functionally inactivated. Interestingly, one form of cancer that typically fails to mutate or lose p53 is retinoblastoma. A recent study of retinoblastoma tumours showed that the genomes of these tumours are relatively stable, even though these cells exhibit chromosome changes and mitotic defects, such as a high incidence of lagging chromosomes, which is associated with aneuploidy in other cell types 69 . Third, understanding how studies in cell lines and tumour models relate to human cancer is complicated by the fact that currently there is no simple way to assess the frequency of chromosome mis-segregation in human tumours. A commonly used substitute for the measurement of CIN is the degree of aneuploidy. However, aneuploidy is not an accurate readout of CIN: the segregation errors that are characteristic of CIN may, or may not, result in aneuploidy, depending on whether the altered genome can be tolerated or whether it affects survival. Moreover, aneuploid cells can also be generated by a one-time defect in mitosis, without the high rate of segregation errors that are characteristic of CIN. Tumours can be highly aneuploid but genomically stable, or exhibit low levels of aneuploidy but high levels of CIN. This makes it difficult to determine which tumour samples exhibit CIN and which do not.
Rather than aneuploidy, a more accurate representation of CIN may be a measure of numerical chromosome heterogeneity in a population of cells. Analysis of a set of tumour cell lines for which numerical heterogeneity has been analysed 70 shows no simple correlation with RB1 status. This may not be surprising because analysis of this same set of tumour cell lines also fails to show a correlation with p53 status, even though mutation of p53 has been shown in numerous model systems to influence genomic stability. The lack of a correlation between CIN and the mutational status of either p53 or RB is perhaps understandable given that most established tumours have lesions in both the p53 and RB pathways. Although a propensity for chromosome segregation errors may be directly linked to RB inactivation, the degree of CIN or aneuploidy that is seen in a developed tumour presumably reflects a more complex balance Figure 3 | The CINful path. Previous models to explain chromosome instability (CIN) and aneuploidy when RB is inactivated have proposed that specific cellular changes (green boxes), such as changes in the expression of mitotic proteins, changes in chromatin structure or defects in replication fork progression ultimately cause defects during mitosis (blue boxes). This figure illustrates that these different aspects of the RB loss-of-function phenotype do not exist in isolation, but are highly interconnected and are likely to influence one another. We suggest that the changes in chromosome segregation and genomic stability that are seen when the RB family proteins are inactivated represent the combined effect of multiple defects.
of factors -including the tolerance of genomic change and the selection for or against specific genotypes -and is unlikely to be attributed to a single gene.
Finally, it is clear that there is not a single answer that applies to all situations. CIN and aneuploidy are not required for tumorigenesis but instead seem to become important when increased genomic variation is advantageous, such as during tumour evolution and relapse. Although RB pathway lesions are found in most tumour cells, these changes are an initiating event in some tumours but a late event in others. A potential explanation for this is that RB pathway lesions have multiple consequences, and that different aspects of the mutant phenotype are advantageous in specific cell types or at different stages of tumour development. In cells in which the p53 pathway is intact, high levels of CIN may be detrimental, perhaps even lethal, in the early stages of tumorigenesis. Lesions in the RB pathway may have very different consequences when additional mutations have occurred that allow the proliferation of aneuploid cells. In situations where RB inactivation is an initiating event, the loss of G1/S regulation by RB may simply outweigh the mitotic defects. Alternatively, these cells may be intrinsically more tolerant of genomic change, or may suppress the mitotic defects.
The challenge for future studies is threefold: to understand more completely why inactivation of RB family members causes CIN and/or aneuploidy, to find ways to prevent these mitotic defects, and to apply this information to specific tumour contexts in which the suppression of CIN and/or aneuploidy is beneficial. Such a comprehensive analysis of how different types of lesions in the RB pathway influence genomic stability may help to delineate a more individualized approach to suppressing CIN and tumour progression.
